Stock Movers

On this episode of Stock Movers:
Amgen (AMGN) shares tumble. Shares of makers of heart drugs like Ionis Pharmaceuticals and Amgen are lower after Novartis AG said its heart medication, pelacarsen, failed in a final-stage study.
Oracle (ORCL) shares gain. Analysts are growing optimistic about the software company’s upcoming results, due after the market close on Thursday. The stock is on track for a fourth straight positive session, and has gained 19% over that stretch.
Bloom Energy (BE) shares gain. Bloom Energy and Everpure shares are rising on Tuesday after S&P Dow Jones Indices said the companies will join the S&P 500 Index, effective prior to the open of trading on Sept. 21.
See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- SpaceX (SPCX) shares rise. SpaceX's weighting in the Nasdaq 100 Index is expected to rise after the index's next rebalancing, which is set to be announced on Friday and take effect on Sept. 21. The increase in weighting could force $12.4 billion of net passive buying from index funds and ETFs, according to revised estimates by JPMorgan Securities strategists.
- Qualcomm (QCOM) shares gain. Qualcomm Inc. said it signed up Amazon.com Inc. as a data center chip customer in a deal that will span "multiple generations" and gives Amazon the right to acquire as much as $4 billion in shares. The tie-up will create customized silicon to support Amazon Web Services artificial intelligence infrastructure, with the two working on chips that run AI services and others that connect computer components.
- Roivant (ROIV) shares climb. The drugmaker said a mid-stage study of its inhaled drug, mosliciguat, met its primary endpoint in the treatment for a lung disease.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Novartis (NOVN) shares are lower as it suffered its third clinical-trial setback in a week after a treatment for a rare muscle-wasting disease failed a late-stage study.
- Boston Scientific (BSX) shares are moving on news it said that fallout from a cybersecurity incident has impacted its ability to ship its products to customers and will cause the medical devices company to miss its sales growth and earnings estimates for the year.
- Intel (INTC) is rising on a report that the company could raise computer chip prices next month.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Novartis (NOVN) shares are lower as it suffered its third clinical-trial setback in a week after a treatment for a rare muscle-wasting disease failed a late-stage study.
- Boston Scientific (BSX) shares are moving on news it said that fallout from a cybersecurity incident has impacted its ability to ship its products to customers and will cause the medical devices company to miss its sales growth and earnings estimates for the year.
- Intel (INTC) is rising on a report that the company could raise computer chip prices next month.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Novartis suffered its third clinical-trial setback in a week after a treatment for a rare muscle-wasting disease failed a late-stage study. Novartis shares plunged as much as 10% in early Zurich trading, reducing their gain for the year to about 4%, trailing rival Roche.
- Computacenter shares climb as much as 7.4%, reaching a record high, after the IT services company upgraded its profit before tax guidance for fiscal year 2026 once again, after doing so at its July trading update. The group also reported a revenue beat in the first half, driven by strong AI-related spend in the US.
- Rubis shares rise as much as 5.3% after the energy solutions firm boosted its Ebitda guidance for the full year.
See omnystudio.com/listener for privacy information.